Home/Filings/4/0001628280-24-027712
4//SEC Filing

HALAS GUS D 4

Accession 0001628280-24-027712

CIK 0001448431other

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 5:48 PM ET

Size

7.2 KB

Accession

0001628280-24-027712

Insider Transaction Report

Form 4
Period: 2024-06-05
HALAS GUS D
Director
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2024-06-0510,0610 total
    Common Stock (10,061 underlying)
  • Exercise/Conversion

    Common Stock

    2024-06-05+10,06180,926 total
Footnotes (2)
  • [F1]Restricted stock units convert into common stock on a one-for-one basis.
  • [F2]On June 7, 2023 the reporting person was granted 10,061 restricted stock units which vested in full on June 5, 2024.

Issuer

OptimizeRx Corp

CIK 0001448431

Entity typeother

Related Parties

1
  • filerCIK 0001230322

Filing Metadata

Form type
4
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 5:48 PM ET
Size
7.2 KB